A case of neonatal sweet syndrome associated with mevalonate kinase deficiency

• Main Authors: Margaret Irwin (Author), Veeraya K. Tanawattanacharoen (Author), Amy Turner (Author), Mary Beth F. Son (Author), Rebecca C. Hale (Author), Craig D. Platt (Author), Juan Putra (Author), Birgitta A.R. Schmidt (Author), Mollie G. Wasserman (Author)
• Format: Book
• Published: BMC, 2023-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.
• Notes: 10.1186/s12969-023-00887-8; 1546-0096
• Keywords: Sweet syndrome; Mevalonate kinase deficiency; Mevalonate kinase-associated diseases; Very early-onset inflammatory bowel disease; Pediatrics; RJ1-570; Diseases of the musculoskeletal system; RC925-935
• Source: Pediatric Rheumatology Online Journal, Vol 21, Iss 1, Pp 1-5 (2023)

Abstract Background Sweet syndrome (SS), also known as acute febrile neutrophilic dermatosis, is an immunologic syndrome characterized by widespread neutrophilic infiltration. Histiocytoid Sweet syndrome (H-SS) is a histopathologic variant of SS. While SS most commonly occurs in adults, this case report discusses an infant patient who presented with H-SS. Case presentation Through a multidisciplinary approach, this patient was also found to have very early onset inflammatory bowel disease (VEO-IBD) and Mevalonate kinase-associated disease (MKAD). While prior case studies have characterized an association between VEO-IBD and MKAD, there is no literature describing the association of all three diagnoses this case: H-SS, VEO-IBD and MKAD. Initiation of canakinumab in this patient resulted in successful control of the disease. Conclusions This case highlights the importance of a multidisciplinary approach to rare diagnoses, and collaboration during cases with significant diagnostic uncertainty.